Orphan Drugs and Expedited Pathways
Regulatory incentives for rare disease therapies and accelerated approval programs.
PharmacologyPost-Marketing Surveillance
Monitoring drug safety after regulatory approval and market introduction.
PharmacologyACE Inhibitors and ARBs
Inhibitors of the renin-angiotensin system for hypertension and heart failure.
PharmacologyAnticoagulants and Antiplatelet Drugs
Drugs that prevent blood clot formation through different mechanisms.
Pharmacology